5XE Stock Chart & Stats
€18.10
€0.05(0.75%)
At close: 4:00 PM EST
€18.10
€0.05(0.75%)
Day’s Range― - ―
52-Week Range€7.65 - €22.60
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€2.19B
Enterprise Value€3.13B
Total Cash (Recent Filing)€322.27M
Total Debt (Recent Filing)€324.56M
Price to Earnings (P/E)26.9
Beta0.45
Next Earnings
Aug 06, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.38
Shares Outstanding95,046,400
10 Day Avg. Volume0
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)4.88
Price to Sales (P/S)1.10
P/FCF Ratio28.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.91Price Target Upside32.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.91
Revenue Forecast (FY)€1.39B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained TTM revenue growth (~5.5%) indicates stable demand for long-term care and home health services, supporting contract renewals and occupancy-driven revenues tied to provincial funding. A steady top line underpins durable cash generation and strategic investments over 2–6 months.
Balance Sheet StrengthMaterial deleveraging and a strengthened equity base materially improve credit profile and financial flexibility. Lower leverage reduces refinancing and covenant risk, enabling the company to fund capex, pursue service growth, or absorb policy shifts without immediate balance-sheet stress.
Margin RecoveryMeaningful rebound in EBITDA and net margins reflects improved cost controls and operating leverage across facilities and services. Higher profitability increases internal cash generation potential and creates a firmer earnings base to support operations and strategic initiatives over the medium term.
Bears Say
Weak Cash ConversionLow and volatile cash conversion (FCF ~39% of net income, declined 23% TTM) signals recurring working-capital or timing drags. This constrains sustained reinvestment, debt reduction and dividend flexibility, making the business more sensitive to shortfalls in earnings or payment/timing shocks.
Material Remaining DebtDespite improved leverage ratios, a ~C$325M debt balance still imposes interest and refinancing obligations. In a higher-rate or tighter liquidity environment, this level of indebtedness can restrict strategic spending, raise financing costs, and limit the firm's ability to respond to sector shocks.
Modest Margins & ExposureNet margins around 5–6% create limited buffer against adverse shifts in wages, occupancy or provincial reimbursement formulas. Given labor intensity of senior care, modest margins elevate operational risk and reduce headroom to absorb policy or cost shocks without cutting services or raising prices.
Extendicare News
5XE FAQ
What was Extendicare’s price range in the past 12 months?
Extendicare lowest stock price was €7.65 and its highest was €22.60 in the past 12 months.
What is Extendicare’s market cap?
Extendicare’s market cap is €2.19B.
When is Extendicare’s upcoming earnings report date?
Extendicare’s upcoming earnings report date is Aug 06, 2026 which is in 21 days.
How were Extendicare’s earnings last quarter?
Extendicare released its earnings results on May 07, 2026. The company reported €0.263 earnings per share for the quarter, beating the consensus estimate of €0.131 by €0.132.
Is Extendicare overvalued?
According to Wall Street analysts Extendicare’s price is currently Undervalued.
Does Extendicare pay dividends?
Extendicare does not currently pay dividends.
What is Extendicare’s EPS estimate?
Extendicare’s EPS estimate is 0.25.
How many shares outstanding does Extendicare have?
Extendicare has 95,046,400 shares outstanding.
What happened to Extendicare’s price movement after its last earnings report?
Extendicare reported an EPS of €0.263 in its last earnings report, beating expectations of €0.131. Following the earnings report the stock price went up 16.31%.
Which hedge fund is a major shareholder of Extendicare?
Currently, no hedge funds are holding shares in DE:5XE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Extendicare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€23.91 (32.13% Upside)
€23.91 (32.13% Upside)
Insider Transactions
Sold Shares
Worth €40.5M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
72.44%
12-Months-Change
Fundamentals
Return on Equity
45.35%
Trailing 12-Months
Asset Growth
50.12%
Trailing 12-Months
Company Description
Extendicare
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
5XE Stock 12 Month Forecast
Average Price Target
€23.91
▲(32.13% Upside)